Five companies have already obtained authorization from the National Medicines Authority (Infarmed) to cultivate, import, and export cannabis for medical purposes. This is still in progress, in several phases, “requests for authorization for various activities such as cultivation, manufacturing, import, export and wholesale distribution,” Infarmed stated in a balance of the first year of cannabis legalization for medical purposes.
Taking stock of the licensing of entities and products under the new legislation, the National Authority of Medicines and Health Products said that “currently there are five entities authorized to cultivate, import and export cannabis plants for medical purposes, with a total authorized area of 120 hectares”.
One of the companies, “Tilray Portugal”, has a certificate of Good Manufacturing Practice, besides the authorization for cultivation, import, and export in the area of Cantanhede and Reguengos de Monsaraz. The other companies with authorization for cultivation, import, and export are “Terra Verde” in Alcochete, “RPK Biopharma” in Sintra and Aljustrel, “Sabores Purpura” in Tavira and “VF 1883 Pharmaceuticals” in Benavente.
As regards applications for authorization to place cannabis preparations on the market for medical purposes, Infarmed reported that two applications have been received, which are “under evaluation”.
Read more at born2invest.com